HSBC Holdings
OKYO

HSBC Holdings’s OKYO Pharma OKYO Stock Holding History

HSBC Holdings’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,933
Closed -$20.3K – 3104
2024
Q2 		$20.3K Hold
11,933
– – ﹤0.01% 2874
2024
Q1 		$20.3K Hold
11,933
– – ﹤0.01% 2993
2023
Q4 		$20.3K Hold
11,933
– – ﹤0.01% 2681
2023
Q3 		$22.1K Hold
11,933
– – ﹤0.01% 2669
2023
Q2 		$13.7K Buy
+11,933
New +$17K ﹤0.01% 2528

Other funds holding OKYO

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CA
Continuum Advisory Eagle, Idaho $1.04B AUM 21.13% 1-Year Est. Return

HSBC Holdings's OKYO Position: Q3 2024 in Review

HSBC Holdings sold out of OKYO Pharma (OKYO) in Q3 2024, closing a stake of 11,933 shares — an estimated $20.3K sold.

HSBC Holdings first reported a position in OKYO in Q2 2023 and held it in 5 quarters. The position peaked at $22.1K in Q3 2023. 6 funds tracked by Wall St. Rank hold OKYO as of Q3 2024.

  • HSBC Holdings reported no remaining OKYO Pharma position as of Q3 2024 after selling out during the quarter.
  • HSBC Holdings sold 11,933 OKYO Pharma shares in Q3 2024, an estimated $20.3K.
  • HSBC Holdings first reported a position in OKYO Pharma in Q2 2023 and held it in 5 quarters.
  • HSBC Holdings's OKYO Pharma position peaked at $22.1K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held OKYO Pharma as of Q3 2024.

Based on HSBC Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.